CSI Market
Sign In | Register

Phasebio Pharmaceuticals (PHAS) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access PHAS quarterly Cash Flow →
By examining cash flow figures across successive periods, users can identify shifts in Phasebio Pharmaceuticals's cash generation and deployment strategy.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2021)
12 Months 		(Dec 31 2020) (Dec 31 2019) (Dec 31 2018)
Operating Activities
Income-131.07
Depreciation & amortization1.79
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation2.27
Income (Loss) from Equity Method Investments0.00
Paid-in-Kind Interest0.30
Gain Loss From Remeasurement Of Derivative Liability21.18
Increase Decrease In Contract With Customer Asset-
Increase Decrease In Contract With Customer Liability28.74
Income taxes0.00
Unrealized Gain (Loss) on Derivatives0.00
Increase (Decrease) in Other Receivables0.00
Increase (Decrease) in Accounts Payable9.01
Increase (Decrease) in Accrued Liabilities3.68
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets7.51
Other Working Capital0.00
Other Noncash Expense0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities9.17
Discontinued operations0.00
Net Cash flow from Operating Activities-47.42
Investing Activities
Capital Expenditures-2.68
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-2.68
Financing Activities
Short-term debt Net0.00
Other borrowing transactions8.18
Long-term debt - borrowings0.00
Long-term debt - repayments-5.46
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock60.71
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Repayment Of Employee Stock Purchase Plans0.34
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities63.77
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-50.10
Total Cash Flow13.68
4 historic quarters locked

Sign in to unlock the full Phasebio Pharmaceuticals cash flow history.

Sign In Create Free Account

About Phasebio Pharmaceuticals Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001169245-22-000093

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License